Total Payments
$119,865
2024 Payments
$913.01
Companies
21
Transactions
464
Medicare Patients
2,038
Medicare Billing
$266,472
Payment Breakdown by Category
Other$85,250 (71.1%)
Travel$21,008 (17.5%)
Food & Beverage$13,543 (11.3%)
Education$63.96 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $85,250 | 39 | 71.1% |
| Travel and Lodging | $21,008 | 61 | 17.5% |
| Food and Beverage | $13,543 | 355 | 11.3% |
| Education | $63.96 | 9 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $63,334 | 104 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $31,488 | 43 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $15,885 | 126 | $0 (2024) |
| Abbott Laboratories | $4,284 | 53 | $0 (2022) |
| Ancora Heart, Inc. | $965.19 | 6 | $0 (2024) |
| ABIOMED | $753.94 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $608.57 | 48 | $0 (2019) |
| United Therapeutics Corporation | $603.18 | 23 | $0 (2021) |
| Medtronic Vascular, Inc. | $577.24 | 5 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $544.36 | 33 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $913.01 | 11 | Ancora Heart, Inc. ($480.32) |
| 2023 | $1,340 | 16 | Ancora Heart, Inc. ($484.87) |
| 2022 | $1,064 | 11 | Abbott Laboratories ($687.09) |
| 2021 | $137.55 | 9 | ABIOMED ($76.84) |
| 2020 | $324.38 | 3 | Medtronic Vascular, Inc. ($202.30) |
| 2019 | $17,246 | 77 | Bayer HealthCare Pharmaceuticals Inc. ($13,794) |
| 2018 | $47,182 | 171 | Gilead Sciences, Inc. ($32,917) |
| 2017 | $51,658 | 166 | Gilead Sciences Inc ($28,525) |
All Payment Transactions
464 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $153.04 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $116.15 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $170.44 | General |
| Category: Cardiovascular | ||||||
| 08/26/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: Cardiology | ||||||
| 07/11/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Cardiology | ||||||
| 06/19/2024 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $156.84 | General |
| Category: Cardiovascular | ||||||
| 04/27/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: Cardiology | ||||||
| 04/11/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $122.32 | General |
| Category: Cardiology | ||||||
| 02/23/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Cardiology | ||||||
| 02/13/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Cardiology | ||||||
| 02/12/2024 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $127.98 | General |
| 12/05/2023 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $293.23 | General |
| Category: Cardiovascular | ||||||
| 12/05/2023 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $2.99 | General |
| Category: Cardiovascular | ||||||
| 11/02/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $146.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/08/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Cardiology | ||||||
| 08/24/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $121.70 | General |
| Category: Cardiology | ||||||
| 08/23/2023 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $188.65 | General |
| Category: Cardiovascular | ||||||
| 08/22/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Cardiology | ||||||
| 08/16/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $37.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/11/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: Cardiology | ||||||
| 07/09/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Cardiology | ||||||
| 06/08/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $108.68 | General |
| Category: Cardiovascular | ||||||
| 05/26/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardiology | ||||||
| 05/25/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $135.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/17/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $4.39 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 478 | 886 | $249,572 | $63,167 |
| 2022 | 16 | 474 | 964 | $274,345 | $67,944 |
| 2021 | 14 | 532 | 889 | $248,616 | $67,052 |
| 2020 | 14 | 554 | 973 | $267,820 | $68,309 |
Total Patients
2,038
Total Services
3,712
Medicare Billing
$266,472
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 45 | 164 | $51,988 | $14,360 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 80 | 185 | $44,030 | $13,199 | 30.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 13 | 41 | $27,593 | $6,988 | 25.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 106 | 123 | $27,888 | $5,939 | 21.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 70 | $15,470 | $3,882 | 25.1% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 13 | 13 | $14,963 | $3,758 | 25.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 28 | $17,248 | $3,654 | 21.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 27 | 27 | $13,797 | $3,107 | 22.5% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 18 | 100 | $14,100 | $2,720 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 12 | $4,044 | $1,268 | 31.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $6,272 | $1,257 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 23 | $3,588 | $1,155 | 32.2% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 12 | 12 | $4,776 | $1,017 | 21.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 13 | 19 | $1,501 | $319.36 | 21.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Facility | 2023 | 25 | 25 | $1,250 | $285.60 | 22.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 27 | 28 | $1,064 | $256.88 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 89 | 221 | $52,598 | $15,370 | 29.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 86 | $57,878 | $13,772 | 23.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 40 | 123 | $38,991 | $9,666 | 24.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 127 | 156 | $35,232 | $8,082 | 22.9% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 14 | 14 | $16,114 | $3,832 | 23.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 69 | $15,249 | $3,827 | 25.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 28 | $17,248 | $3,687 | 21.4% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2022 | 13 | 104 | $14,664 | $3,209 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 21 | 21 | $8,232 | $2,079 | 25.3% |
About Dr. Ernest Haeusslein, M.D
Dr. Ernest Haeusslein, M.D is a Cardiovascular Disease healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780617571.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ernest Haeusslein, M.D has received a total of $119,865 in payments from pharmaceutical and medical device companies, with $913.01 received in 2024. These payments were reported across 464 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($85,250).
As a Medicare-enrolled provider, Haeusslein has provided services to 2,038 Medicare beneficiaries, totaling 3,712 services with total Medicare billing of $266,472. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Austin, TX
- Active Since 07/08/2006
- Last Updated 12/12/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780617571
Products in Payments
- Letairis (Drug) $40,743
- Adempas (Drug) $31,488
- OPSUMIT MACITENTAN (Drug) $5,114
- Circulatory Support (Device) $1,579
- UPTRAVI (Drug) $985.72
- AccuCinch (Device) $965.19
- HeartMate (Device) $926.93
- CardioMEMS HF System (Device) $876.45
- Impella (Device) $753.94
- ENTRESTO (Drug) $608.57
- HeartWare HVAD (Device) $577.24
- LifeVest (Device) $544.36
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $512.84
- ORENITRAM (Drug) $445.26
- OPSUMIT (Drug) $264.35
- HeartMate 3 Left Ventricular Dev (Device) $182.98
- CARDIOMEMS (Device) $174.25
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $146.71
- Barostim Neo System (Device) $133.03
- BREZTRI (Drug) $116.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Austin
Dr. Andrea Natale, Md, MD
Cardiovascular Disease — Payments: $1.4M
Cardiovascular Disease $1.4M
Dr. Jason Zagrodzky, M.d, M.D
Cardiovascular Disease — Payments: $953,600
Cardiovascular Disease $953,600
Dr. Rodney Horton, M.d, M.D
Cardiovascular Disease — Payments: $720,616
Cardiovascular Disease $720,616
Francis Zidar, Md, MD
Cardiovascular Disease — Payments: $448,847
Cardiovascular Disease $448,847
Vivek Goswami, Md, MD
Cardiovascular Disease — Payments: $338,027
Cardiovascular Disease $338,027
Dr. Robert Canby, M.d, M.D
Cardiovascular Disease — Payments: $225,010
Cardiovascular Disease $225,010